Current Neuro-Oncology
Volume
24 Number 8
30 April 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 8, 30 April
DeWire
M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek
J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson
CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L,
Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi
M.
Phase
I study of ribociclib and everolimus in children with newly
diagnosed DIPG and high-grade glioma: A CONNECT pediatric
neuro-oncology consortium report.
Neurooncol
Adv. 2022 Apr 16;4(1):vdac055∟.
doi: 10.1093/noajnl/vdac055∟.
PMID: 35611273∟.
Interventional study. ˍ
Caramanti
R, Aprígio RM, D Aglio Rocha CE, Morais DF, Góes MJ,
Chaddad-Neto F, Tognola WA.
Is
Edema Zone Volume Associated With Ki-67 Index in Glioblastoma
Patients?
Cureus.
2022 Apr 18;14(4):e24246∟.
doi: 10.7759/cureus.24246∟.
PMID: 35602791∟.
Observational study. ˍ
Flies
CM, van Leuken KH, Voorde MT, Verhoeff JJC, De Vos FYF, Seute T,
Robe PA, Witkamp TD, Hendrikse J, Dankbaar JW, Snijders
TJ.
Conventional
MRI Criteria to
Differentiate Progressive Disease from Treatment-Induced Effects
in High-Grade (WHO Grade 3-4) Gliomas.
Neurology.
2022
Apr 18;99(1):e77-e88∟.
doi: 10.1212/WNL.0000000000200359∟.
PMID: 35437259∟.
Observational study. ˍ
Dang
H, Zhang J, Wang R, Liu J, Fu H, Lin M, Xu B.
Glioblastoma
Recurrence
Versus
Radiotherapy Injury: Combined Model of Diffusion Kurtosis Imaging
and 11C-MET
Using PET/MRI May Increase Accuracy of Differentiation.
Clin
Nucl Med. 2022 Apr 19∟.
doi: 10.1097/RLU.0000000000004167∟.
PMID: 35439178∟.
Observational study˰ ˍ
Furtak
J, Kwiatkowski A, Śledzińska P, Bebyn M, Krajewski S,
Szylberg T, Birski
M, Druszcz A, Krystkiewicz K, Gasiński P, Harat M.
Survival
after
reoperation
for recurrent glioblastoma multiforme: A prospective study.
Surg
Oncol.
2022 Apr 20;42:101771∟.
doi: 10.1016/j.suronc.2022.101771∟.
PMID: 35512545∟.
Interventional
study˰ ˍ
Klingenschmid
J, Krigers A, Pinggera D, Kerschbaumer J, Thomé C,
Freyschlag CF.
The
Clinical Frailty Scale as predictor of overall survival after
resection of
high-grade glioma.
J
Neurooncol. 2022 Apr 25∟.
doi: 10.1007/s11060-022-04001-y∟.
PMID: 35467234∟.
Observational study. ˍ
Sangrador-Deitos
MV, Villanueva-Castro E, Marian-Magaña R,
Rodríguez-Hernández LA, Guinto-Nishimura GY,
Gómez-Amador JL, Corona-Vázquez T, Wegman-Ostorozky
T, Mejia S.
Carboplatin
Plus Vincristine as an Alternative Chemotherapeutic Scheme in
Patients With Glioblastoma.
Cureus.
2022 Apr 25;14(4):e24467∟.
doi: 10.7759/cureus.24467∟.
PMID: 35637821∟.
Observational study. ˍ
Wach
J, Güresir Á, Hamed M, Vatter H, Herrlinger U, Güresir
E.
Impact
of Levetiracetam
Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1
Wild-Type
Glioblastoma.
Cancers
(Basel). 2022 Apr 25;14(9):2134∟.
doi: 10.3390/cancers14092134∟.
PMID: 35565263∟.
Observational study. ˍ
Jiao
Y, Wang M, Liu X, Wang J, Shou Y, Sun H.
Clinical
features and
prognostic
significance of tumor involved with subventricular zone in
pediatric
glioblastoma:
a 10-year experience in a single hospital.
Childs
Nerv Syst. 2022 Apr 26∟.
doi: 10.1007/s00381-022-05522-7∟.
PMID: 35474540∟.
Observational study˰ ˍ
Kavouridis
VK, Ligon KL, Wen PY, Iorgulescu JB.
Survival
outcomes associated
with
MGMT promoter methylation and temozolomide in gliosarcoma
patients.
J
Neurooncol. 2022 Apr 26∟.
doi: 10.1007/s11060-022-04016-5∟.
PMID: 35474499∟.
Observational study˰ ˍ
Lauretti
L, Cenci T, Montano N, Offi M, Giordano M, Caccavella VM,
Mangraviti A, Agostini L, Olivi A, Gabriele L, Larocca LM, Pallini
R, Martini M, D'Alessandris QG.
Molecular
Analysis in a Glioblastoma Cohort-Results of a Prospective
Analysis.
J
Pers Med. 2022 Apr 26;12(5):685∟.
doi: 10.3390/jpm12050685∟.
PMID: 35629107∟.
Observational study. ˍ
Alonzo
F, Serandour AA, Saad M.
Simulating
the behaviour of glioblastoma
multiforme
based on patient MRI during treatments.
J
Math Biol. 2022 Apr 28;84(6):44∟.
doi: 10.1007/s00285-022-01747-x∟.
PMID: 35482133∟.
Laboratory investigation˰ ˍ
*
Ohnishi
T, Yamashita D, Inoue A, Suehiro S, Ohue S, Kunieda T.
Is
Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective
against Local Recurrence of Glioblastoma? A Pharmacokinetic Study
by Measurement of BCNU in the Tumor Resection Cavity.
Brain
Sci. 2022 Apr 28;12(5):567∟.
doi: 10.3390/brainsci12050567∟.
PMID: 35624954∟.
Observational study.
ˍ
Annereau
M, Hinterlang M, Bienayme H, Vassal G, Pinon A, Schmitt M, Denis
L, Lemarchand C, Martin L, Lemare F, Abbou S, Bastid J, Tortolano
L.
Development
of a Hospital Compounded, Taste-Masked, Temozolomide Oral
Suspension and 5-Year Real-Life Experience in Treating Paediatric
Patients.
Pharmaceuticals
(Basel). 2022 Apr 29;15(5):555∟.
doi: 10.3390/ph15050555∟.
PMID: 35631381∟.
Observational study.
ˍ
Bs
A, B A, R S H, V V, Mahadevan A, Pandya HJ.
Electromechanical
Characterization
of Human Brain Tissues: A Potential Biomarker for Tumor
Delineation.
IEEE
Trans Biomed Eng. 2022 Apr 29;69(11):3484-3493∟.
doi: 10.1109/TBME.2022.3171287∟.
PMID: 35486560∟.
Laboratory investigation˰ ˍ
Miller
R, Song A, Ali A, Niazi M, Bar-Ad V, Martinez N, Glass J, Alnahhas
I, Andrews D, Judy K, Evans J, Farrell C, Werner-Wasik M,
Chervoneva I, Ly M, Palmer J, Liu H, Shi W.
Scalp-Sparing
Radiation With Concurrent Temozolomide and Tumor Treating Fields
(SPARE) for Patients With Newly Diagnosed Glioblastoma.
Front
Oncol. 2022 Apr 29;12:896246∟.
doi: 10.3389/fonc.2022.896246∟.
PMID: 35574391∟.
Interventional study. ˍ
*
Morimoto
T, Matsuda R, Nakazawa T, Nishimura F, Nakagawa I.
Combined
Treatment
With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase
Mutant
Brainstem Glioma in Adult: A Case Report.
Brain
Tumor Res Treat. 2022 Apr
29;10(2):129-133∟.
doi: 10.14791/btrt.2022.0009∟.
PMID: 35545834∟.
Case
report. ˍ
Postnov
A, Toutain J, Pronin I, Valable S, Gourand F, Kalaeva D, Vikhrova
N, Pyzhik E, Guillouet S, Kobyakov G, Khokholova E, Pitskhelauri
D, Usachev D, Maryashev S, Rizhova M, Potapov A, Derlon
JM.
First-in-Man
Noninvasive Initial
Diagnostic
Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET
With
18F-Fludarabine
and l-[methyl-11C]Methionine.
Clin
Nucl Med. 2022 Apr 29∟.
doi: 10.1097/RLU.0000000000004238∟.
PMID: 35485864∟.
Observational study˰
ˍ